CCIS, historically known as California Cryobank Life Sciences, has been a prominent name in the field of reproductive and stem cell services for over four decades. Specializing in the cryopreservation of sperm, eggs, and embryos, as well as cord blood and tissue banking (through its former division FamilyCord), CCIS provided vital services to individuals and families worldwide. Founded in 1977, it grew to become one of the largest full-service cryobanks. In 2018, CCIS was acquired by GI Partners and merged with Cord Blood Registry to form Generate Life Sciences. Subsequently, in 2021, Generate Life Sciences was acquired by CooperSurgical, and CCIS's operations and legacy now continue as part of CooperSurgical's comprehensive offerings in women's health and fertility.
Served as the primary administrative center, main laboratory for processing and cryostorage, research and development hub, and client services coordination point.
State-of-the-art laboratory facilities designed for long-term cryogenic storage, advanced reproductive material processing labs, and secure client record management systems.
A scientifically-driven environment emphasizing precision, patient care, ethical practices, and innovation in reproductive and stem cell technologies. Collaborative with a strong focus on quality control and research.
The Los Angeles HQ was central to establishing CCIS as a global leader in its field, pioneering many techniques and standards in cryopreservation and donor services.
While its physical laboratories and primary offices were U.S.-based, CCIS (California Cryobank) maintained a significant global presence. It served an international clientele by shipping donor sperm and eggs to numerous countries worldwide, adhering to varying international regulations. Its services were utilized by individuals and fertility clinics across North America, Europe, Asia, Australia, and other regions, making it a global resource in reproductive medicine.
11915 La Grange Ave
Los Angeles
CA
USA
Address: 119 W 57th St #1215, New York, NY 10019 (historical)
Catered to clients in the New York metropolitan area and the broader Northeastern United States, offering convenient access to services.
Address: 3875 El Camino Real Ste A, Palo Alto, CA 94306 (historical)
Offered local access for a technologically savvy demographic and supported partnerships with fertility clinics in the Bay Area.
Address: 950 Massachusetts Ave, Cambridge, MA 02139 (historical)
Supported clients and fertility clinics throughout New England, leveraging proximity to Boston's renowned medical and research institutions.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, CCIS' leadership includes:
CCIS has been backed by several prominent investors over the years, including:
As CCIS (California Cryobank) was acquired by GI Partners in 2018 to form Generate Life Sciences, and Generate Life Sciences was subsequently acquired by CooperSurgical in 2021, CCIS no longer operates as an independent entity with its own executive team. Leadership changes now occur within the CooperSurgical (CooperSurgical Fertility Solutions) structure. Therefore, there are no CCIS-specific executive hires or exits in the last 12 months.
Discover the tools CCIS uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Based on common corporate email patterns for companies like California Cryobank (cryobank.com), the likely email formats included first initial followed by last name, or first name.last name. The domain used would have been @cryobank.com.
[first_initial][last]@cryobank.com, [first].[last]@cryobank.com
Format
jdoe@cryobank.com, jane.doe@cryobank.com
Example
65%
Success rate
CooperCompanies Press Release • December 15, 2021
CooperCompanies announced the successful completion of its acquisition of Generate Life Sciences, a leading provider of donor egg and sperm for fertility treatments, fertility cryopreservation services, and newborn stem cell storage. Generate Life Sciences was formed from the merger of California Cryobank (CCIS) and Cord Blood Registry....more
GI Partners Press Release • August 1, 2018
GI Partners, a leading private equity firm, announced it completed the acquisitions of California Cryobank (CCIS) and Cord Blood Registry (CBR). The two companies were combined to create Generate Life Sciences, a new company for reproductive, stem cell, and genetic services....more
California Cryobank Blog (Archive) • July 12, 2017
California Cryobank (CCIS) celebrated its 40th anniversary, marking four decades of service in providing sperm banking, reproductive services, and, through its FamilyCord division, cord blood and tissue banking. The milestone highlighted its long-standing commitment to helping build families....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including CCIS, are just a search away.